$CTRE

CareTrust REIT, Inc.

1
1
0

No SEC Form 4 filings for $CTRE in the last 30 days.

See all $CTRE insider activity →

JPMorgan initiates CareTrust REIT stock coverage with neutral rating

JPMorgan initiated coverage on CareTrust REIT (CTRE) with a Neutral rating and a $41.00 price target for 2027, citing strong earnings growth and acquisition activity. Revenue surged 53% to $571 million over the last year. The company is expanding into the UK and senior housing, with recent acquisitions totaling $1.9 billion. Analysts have mixed price targets, ranging from $42 to $46.

CTRE sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning CTRE (CareTrust REIT, Inc.). Coverage has skewed bullish: 1 bullish, 1 neutral, and 0 bearish.

Recent CTRE coverage spans mergers & acquisitions, financial news and sector analysis.

What's driving CTRE

AlphAI scores every news story that mentions CTRE with an AI model for sentiment and relevance, and aggregates insider trades from CareTrust REIT, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $CTRE

Score
$CTREMed

JPMorgan initiates CareTrust REIT stock coverage with neutral rating

JPMorgan initiated coverage on CareTrust REIT (CTRE) with a Neutral rating and a $41.00 price target for 2027, citing strong earnings growth and acquisition activity. Revenue surged 53% to $571 million over the last year. The company is expanding into the UK and senior housing, with recent acquisitions totaling $1.9 billion. Analysts have mixed price targets, ranging from $42 to $46.

$CTREMedAI 8/10

CareTrust REIT stock rating maintained at outperform by Citizens

Citizens maintained a Market Outperform rating and $44.00 price target on CareTrust REIT (CTRE) following its $1.4B acquisition of 45 UK care homes. CTRE trades at $36.64, with analysts citing potential upside. The REIT has a 4.26% dividend yield and a 'GREAT' financial health score of 3.45/5. Other analysts have mixed price targets, ranging from $42 to $47.

$CTREMedAI 8/10

BMO cuts CareTrust REIT stock price target on UK acquisition

BMO Capital reduced its price target for CareTrust REIT (CTRE) to $45 from $47, citing a £1.1 billion UK acquisition. The company plans to transition the properties and expects a 7.8% yield. CTRE's stock has a P/E ratio of 22.8 and a PEG ratio of 0.75. The firm increased its 2027 funds available for distribution estimate to $2.17 per share. Analysts have mixed views on CTRE's valuation and growth prospects.

Related tickers